Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MCRB | AMGN | VRTX | REGN | GSK |
| Company | Seres Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.7523 | 302.29 | 481.82 | 998.08 | 41.05 |
| High | 0.8500 | 302.58 | 483.23 | 1,016.99 | 41.36 |
| Low | 0.7200 | 299.80 | 478.38 | 997.84 | 40.89 |
| Last | 0.7947 | 300.70 | 481.53 | 1,010.54 | 41.06 |
| Change | +0.0546 | -4.02 | -1.75 | +8.81 | -0.23 |
| % Change | +7.38% | -1.32% | -0.36% | +0.88% | -0.56% |
| Volume | 4,296,900 | 1,740,100 | 882,000 | 448,200 | 2,379,000 |
| 20-Day Average Volume | 4,601,520 | 2,294,745 | 1,222,095 | 391,830 | 4,255,170 |
| Previous Close | 0.7401 | 304.72 | 483.28 | 1,001.73 | 41.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9218 | 307.52 | 457.15 | 986.90 | 43.65 |
| 20-Day Raw Stochastic | 38.13% | 20.08% | 92.35% | 90.03% | 10.16% |
| 20-Day Relative Strength | 46.03% | 51.72% | 72.61% | 63.92% | 40.89% |
| Weighted Alpha | -87.28 | +27.25 | +43.97 | +31.23 | +15.24 |
| Today's Opinion | 80% Sell | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 80% Sell | 80% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 32% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -25.73% since 06/04/24 | -2.17% since 06/04/24 | +1.39% since 06/04/24 | +1.74% since 06/04/24 | -0.70% since 06/04/24 |
| Low | 0.5634 on 06/07/24 | 299.80 on 06/11/24 | 474.16 on 06/05/24 | 989.77 on 06/05/24 | 40.89 on 06/11/24 |
| High | 1.1700 on 06/05/24 | 310.31 on 06/05/24 | 486.42 on 06/07/24 | 1,016.99 on 06/11/24 | 42.44 on 06/05/24 |
| 1-Month | |||||
| %Chg | -22.09% since 05/10/24 | -3.05% since 05/10/24 | +13.90% since 05/10/24 | +3.77% since 05/10/24 | -8.90% since 05/10/24 |
| Low | 0.5634 on 06/07/24 | 295.49 on 05/30/24 | 422.44 on 05/14/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 1.1700 on 06/05/24 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,016.99 on 06/11/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -7.59% since 03/11/24 | +9.20% since 03/11/24 | +16.18% since 03/11/24 | +4.78% since 03/11/24 | -4.33% since 03/11/24 |
| Low | 0.5400 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 1.2800 on 05/06/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,016.99 on 06/11/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -20.28% since 12/11/23 | +10.49% since 12/11/23 | +35.15% since 12/11/23 | +19.11% since 12/11/23 | +12.90% since 12/11/23 |
| Low | 0.5400 on 04/19/24 | 260.68 on 04/19/24 | 355.66 on 12/12/23 | 838.46 on 12/21/23 | 35.87 on 12/15/23 |
| High | 2.0500 on 01/09/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,016.99 on 06/11/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 112,087 | 163,462,464 | 124,711,856 | 110,376,608 | 85,571,048 |
| Shares Outstanding, K | 151,448 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 126,330,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -113,720,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 60,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -41,250,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.95 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/08/24 | 08/01/24 | 05/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.37 | 32.07 | 27.03 | 10.20 |